The protein encoded by this gene is a transformation and shape-change sensitive actin cross-linking/gelling protein found in fibroblasts and smooth muscle. Its expression is down-regulated in many cell lines, and this down-regulation may be an early and sensitive marker for the onset of transformation. A functional role of this protein is unclear. Two transcript variants encoding the same protein have been found for this gene.[3]
References
↑Kobayashi R, Kubota T, Hidaka H (Mar 1994). "Purification, characterization, and partial sequence analysis of a new 25-kDa actin-binding protein from bovine aorta: a SM22 homolog". Biochem Biophys Res Commun. 198 (3): 1275–80. doi:10.1006/bbrc.1994.1180. PMID8117285.
↑Thweatt R, Lumpkin CK Jr, Goldstein S (Oct 1992). "A novel gene encoding a smooth muscle protein is overexpressed in senescent human fibroblasts". Biochem Biophys Res Commun. 187 (1): 1–7. doi:10.1016/S0006-291X(05)81449-4. PMID1520290.
Nishida W, Kitami Y, Abe M, Hiwada K (1991). "Gene cloning and nucleotide sequence of SM22 alpha from the chicken gizzard smooth muscle". Biochem. Int. 23 (4): 663–8. PMID1872880.
Nagase T, Miyajima N, Tanaka A, et al. (1995). "Prediction of the coding sequences of unidentified human genes. III. The coding sequences of 40 new genes (KIAA0081-KIAA0120) deduced by analysis of cDNA clones from human cell line KG-1". DNA Res. 2 (1): 37–43. doi:10.1093/dnares/2.1.37. PMID7788527.
Maruyama K, Sugano S (1994). "Oligo-capping: a simple method to replace the cap structure of eukaryotic mRNAs with oligoribonucleotides". Gene. 138 (1–2): 171–4. doi:10.1016/0378-1119(94)90802-8. PMID8125298.
Li L, Liu Z, Mercer B, et al. (1997). "Evidence for serum response factor-mediated regulatory networks governing SM22alpha transcription in smooth, skeletal, and cardiac muscle cells". Dev. Biol. 187 (2): 311–21. doi:10.1006/dbio.1997.8621. PMID9242426.
Yamamura H, Masuda H, Ikeda W, et al. (1997). "Structure and expression of the human SM22alpha gene, assignment of the gene to chromosome 11, and repression of the promoter activity by cytosine DNA methylation". J. Biochem. 122 (1): 157–67. doi:10.1093/oxfordjournals.jbchem.a021722. PMID9276683.
Suzuki Y, Yoshitomo-Nakagawa K, Maruyama K, et al. (1997). "Construction and characterization of a full length-enriched and a 5'-end-enriched cDNA library". Gene. 200 (1–2): 149–56. doi:10.1016/S0378-1119(97)00411-3. PMID9373149.
Lawson D, Harrison M, Shapland C (1998). "Fibroblast transgelin and smooth muscle SM22alpha are the same protein, the expression of which is down-regulated in many cell lines". Cell Motil. Cytoskeleton. 38 (3): 250–7. doi:10.1002/(SICI)1097-0169(1997)38:3<250::AID-CM3>3.0.CO;2-9. PMID9384215.
Camoretti-Mercado B, Forsythe SM, LeBeau MM, et al. (1998). "Expression and cytogenetic localization of the human SM22 gene (TAGLN)". Genomics. 49 (3): 452–7. doi:10.1006/geno.1998.5267. PMID9615232.
Fu Y, Liu HW, Forsythe SM, et al. (2001). "Mutagenesis analysis of human SM22: characterization of actin binding". J. Appl. Physiol. 89 (5): 1985–90. PMID11053353.
Shields JM, Rogers-Graham K, Der CJ (2002). "Loss of transgelin in breast and colon tumors and in RIE-1 cells by Ras deregulation of gene expression through Raf-independent pathways". J. Biol. Chem. 277 (12): 9790–9. doi:10.1074/jbc.M110086200. PMID11773051.
Chainiaux F, Magalhaes JP, Eliaers F, et al. (2002). "UVB-induced premature senescence of human diploid skin fibroblasts". Int. J. Biochem. Cell Biol. 34 (11): 1331–9. doi:10.1016/S1357-2725(02)00022-5. PMID12200029.
Xu R, Ho YS, Ritchie RP, Li L (2003). "Human SM22 alpha BAC encompasses regulatory sequences for expression in vascular and visceral smooth muscles at fetal and adult stages". Am. J. Physiol. Heart Circ. Physiol. 284 (4): H1398–407. doi:10.1152/ajpheart.00737.2002. PMID12521938.
Rual JF, Venkatesan K, Hao T, et al. (2005). "Towards a proteome-scale map of the human protein-protein interaction network". Nature. 437 (7062): 1173–8. doi:10.1038/nature04209. PMID16189514.
Yang Z, Chang YJ, Miyamoto H, et al. (2007). "Transgelin functions as a suppressor via inhibition of ARA54-enhanced androgen receptor transactivation and prostate cancer cell growth". Mol. Endocrinol. 21 (2): 343–58. doi:10.1210/me.2006-0104. PMID17082327.
Liao X, Li S, Lou Z, et al. (2007). "Crystallization and preliminary crystallographic analysis of transgelin". Protein Pept. Lett. 14 (2): 209–11. doi:10.2174/092986607779816122. PMID17305610.